CKD

You have accessRestricted Access
Kidney Disease-Associated APOL1 Variants Have Dose-Dependent, Dominant Toxic Gain-of-Function
Somenath Datta, Rama Kataria, Jia-Yue Zhang, Savannah Moore, Kaitlyn Petitpas, Adam Mohamed, Nathan Zahler, Martin R. Pollak and Opeyemi A. Olabisi

JASN July 2020, ASN.2020010079; DOI: https://doi.org/10.1681/ASN.2020010079

Add to Selected Citations
You have accessRestricted Access
Incident Chronic Kidney Disease Risk among Hispanics/Latinos in the United States: The Hispanic Community Health Study/Study of Latinos (HCHS/SOL)
Ana C. Ricardo, Matthew Shane Loop, Franklyn Gonzalez, Claudia M. Lora, Jinsong Chen, Nora Franceschini, Holly J. Kramer, Stephanie M. Toth-Manikowski, Gregory A. Talavera, Martha Daviglus and James P. Lash

JASN June 2020, 31 (6) 1315-1324; DOI: https://doi.org/10.1681/ASN.2019101008

Add to Selected Citations
You have accessRestricted Access
Tubule-Specific Mst1/2 Deficiency Induces CKD via YAP and Non-YAP Mechanisms
Chunhua Xu, Li Wang, Yu Zhang, Wenling Li, Jinhong Li, Yang Wang, Chenling Meng, Jinzhong Qin, Zhi-Hua Zheng, Hui-Yao Lan, Kingston King-Lun Mak, Yu Huang and Yin Xia

JASN May 2020, 31 (5) 946-961; DOI: https://doi.org/10.1681/ASN.2019101052

Add to Selected Citations
You have accessRestricted Access
Competing Risk Modeling: Time to Put it in Our Standard Analytical Toolbox
Liang Li, Wei Yang, Brad C. Astor and Tom Greene

JASN December 2019, 30 (12) 2284-2286; DOI: https://doi.org/10.1681/ASN.2019101011

Add to Selected Citations
Open Access
A Pilot Randomized Trial of Ferric Citrate Coordination Complex for the Treatment of Advanced CKD
Geoffrey A. Block, Martha S. Block, Gerard Smits, Rupal Mehta, Tamara Isakova, Myles Wolf and Glenn M. Chertow

JASN August 2019, 30 (8) 1495-1504; DOI: https://doi.org/10.1681/ASN.2018101016

Add to Selected Citations
Open Access
Staying the Course: Through End of Life in ESRD
Erica Perry, Sally Joy and Richard Swartz

JASN March 2019, 30 (3) 373-374; DOI: https://doi.org/10.1681/ASN.2019010020

Add to Selected Citations
You have accessRestricted Access
Biallelic Expression of Mucin-1 in Autosomal Dominant Tubulointerstitial Kidney Disease: Implications for Nongenetic Disease Recognition
Karl X. Knaup, Thomas Hackenbeck, Bernt Popp, Johanna Stoeckert, Andrea Wenzel, Maike Büttner-Herold, Frederick Pfister, Markus Schueler, Didem Seven, Annette M. May, Jan Halbritter, Hermann-Josef Gröne, André Reis, Bodo B. Beck, Kerstin Amann, Arif B. Ekici and Michael S. Wiesener

JASN September 2018, 29 (9) 2298-2309; DOI: https://doi.org/10.1681/ASN.2018030245

Add to Selected Citations
You have accessRestricted Access
Novel Approaches for Assessment of Bone Turnover in CKD: Is New Always Better?
Elvira O. Gosmanova and Aidar R. Gosmanov

JASN September 2018, 29 (9) 2443; DOI: https://doi.org/10.1681/ASN.2018050561

Add to Selected Citations
You have accessRestricted Access
Authors' Reply
Syazrah Salam, Arif Khwaja and Richard Eastell

JASN September 2018, 29 (9) 2444; DOI: https://doi.org/10.1681/ASN.2018060647

Add to Selected Citations
You have accessRestricted Access
The Authors Reply
Steven G. Coca, Girish N. Nadkarni, Kinsuk Chauhan and Chirag R. Parikh

JASN June 2018, 29 (6) 1782-1783; DOI: https://doi.org/10.1681/ASN.2018020164

Add to Selected Citations

Main menu

User menu

Search

CKD

Pages

About

Author Information

More Information